Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Pancreas"
DOI: 10.1097/mpa.0000000000001319
Abstract: Objectives Neuroendocrine differentiation in pancreatic ductal adenocarcinoma (PDAC) is known, but its clinical significance still remains uncertain. The clinical role of chromogranin A (CgA), a marker of neuroendocrine tumor, was evaluated in patients with PDAC.… read more here.
Keywords: cga; high cga; pancreatic ductal; ductal adenocarcinoma ... See more keywords